Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators.

Lancet Gastroenterol Hepatol. 2019 Dec;4(12):960-970. doi: 10.1016/S2468-1253(19)30265-1. Epub 2019 Sep 4.

PMID:
31494097
2.

Microbiology and immunology: An ideal partnership for a tango at the gut surface-A tribute to Philippe Sansonetti.

Cerf-Bensussan N.

Cell Microbiol. 2019 Nov;21(11):e13097. doi: 10.1111/cmi.13097. Epub 2019 Aug 26.

PMID:
31414516
3.

Recent advances in celiac disease and refractory celiac disease.

Malamut G, Cording S, Cerf-Bensussan N.

F1000Res. 2019 Jun 26;8. pii: F1000 Faculty Rev-969. doi: 10.12688/f1000research.18701.1. eCollection 2019. Review.

4.

Scratching Beneath the Surface: Linking Skin Pathology with Food Allergy.

Cherrier M, Cerf-Bensussan N.

Immunity. 2019 May 21;50(5):1124-1126. doi: 10.1016/j.immuni.2019.04.013.

PMID:
31117007
5.

A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult.

Al Nabhani Z, Dulauroy S, Marques R, Cousu C, Al Bounny S, Déjardin F, Sparwasser T, Bérard M, Cerf-Bensussan N, Eberl G.

Immunity. 2019 May 21;50(5):1276-1288.e5. doi: 10.1016/j.immuni.2019.02.014. Epub 2019 Mar 19.

PMID:
30902637
6.

Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity.

Martínez-López M, Iborra S, Conde-Garrosa R, Mastrangelo A, Danne C, Mann ER, Reid DM, Gaboriau-Routhiau V, Chaparro M, Lorenzo MP, Minnerup L, Saz-Leal P, Slack E, Kemp B, Gisbert JP, Dzionek A, Robinson MJ, Rupérez FJ, Cerf-Bensussan N, Brown GD, Bernardo D, LeibundGut-Landmann S, Sancho D.

Immunity. 2019 Feb 19;50(2):446-461.e9. doi: 10.1016/j.immuni.2018.12.020. Epub 2019 Jan 29.

7.

Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation.

Parlato M, Charbit-Henrion F, Abi Nader E, Begue B, Guegan N, Bruneau J, Khater S, Macintyre E, Picard C, Frédéric RL, Le Bourhis L, Allez M, Goulet O, Cellier C, Hermine O, Cerf-Bensussan N, Malamut G.

Gastroenterology. 2019 Mar;156(4):1206-1210.e1. doi: 10.1053/j.gastro.2018.11.065. Epub 2018 Dec 15. No abstract available. Erratum in: Gastroenterology. 2019 Jun;156(8):2356.

8.

NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.

Cheminant M, Bruneau J, Malamut G, Sibon D, Guegan N, van Gils T, Cording S, Trinquand A, Verkarre V, Lhermitte L, Brousse N, Jannot AS, Khater S, Frenzel L, Delarue R, Suarez F, Marçais A, Mulder CJ, Macintyre E, Asnafi V, Pouyet L, Bonnafous C, Lhospice F, Molina TJ, Meresse B, Cellier C, Cerf-Bensussan N, Hermine O; CELAC network°.

Gut. 2019 Aug;68(8):1396-1405. doi: 10.1136/gutjnl-2018-317371. Epub 2018 Nov 17.

PMID:
30448772
9.

Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study.

Duclaux-Loras R, Charbit-Henrion F, Neven B, Nowak J, Collardeau-Frachon S, Malcus C, Ray PF, Moshous D, Beltrand J, Goulet O, Cerf-Bensussan N, Lachaux A, Rieux-Laucat F, Ruemmele FM.

Clin Transl Gastroenterol. 2018 Nov 2;9(10):201. doi: 10.1038/s41424-018-0064-x.

10.

Copy number variations and founder effect underlying complete IL-10Rβ deficiency in Portuguese kindreds.

Charbit-Henrion F, Bègue B, Sierra A, Hanein S, Stolzenberg MC, Li Z, Pellegrini S, Garcelon N, Jeanpierre M, Neven B, Loge I, Picard C, Rosain J, Bustamante J, Le Lorc'h M, Pigneur B, Fernandes A; GENIUS Group, Rieux-Laucat F, Amil Dias J, Ruemmele FM, Cerf-Bensussan N.

PLoS One. 2018 Oct 26;13(10):e0205826. doi: 10.1371/journal.pone.0205826. eCollection 2018.

11.

Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease.

Paulin MV, Couronné L, Beguin J, Le Poder S, Delverdier M, Semin MO, Bruneau J, Cerf-Bensussan N, Malamut G, Cellier C, Benchekroun G, Tiret L, German AJ, Hermine O, Freiche V.

BMC Vet Res. 2018 Oct 11;14(1):306. doi: 10.1186/s12917-018-1635-5. Review.

12.

A Single-Tube, EuroClonality-Inspired, TRG Clonality Multiplex PCR Aids Management of Patients with Enteropathic Diseases, including from Formaldehyde-Fixed, Paraffin-Embedded Tissues.

Derrieux C, Trinquand A, Bruneau J, Verkarre V, Lhermitte L, Alcantara M, Villarese P, Meresse B, Sibon D, Hermine O, Brousse N, Molina T, Cellier C, Cerf-Bensussan N, Malamut G, Macintyre E.

J Mol Diagn. 2019 Jan;21(1):111-122. doi: 10.1016/j.jmoldx.2018.08.006. Epub 2018 Sep 28.

PMID:
30268943
13.

Modulation of the gut microbiota to improve innate resistance.

Schnupf P, Gaboriau-Routhiau V, Cerf-Bensussan N.

Curr Opin Immunol. 2018 Oct;54:137-144. doi: 10.1016/j.coi.2018.08.003. Epub 2018 Sep 8. Review.

PMID:
30205357
14.

Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study.

Charbit-Henrion F, Parlato M, Hanein S, Duclaux-Loras R, Nowak J, Begue B, Rakotobe S, Bruneau J, Fourrage C, Alibeu O, Rieux-Laucat F, Lévy E, Stolzenberg MC, Mazerolles F, Latour S, Lenoir C, Fischer A, Picard C, Aloi M, Amil Dias J, Ben Hariz M, Bourrier A, Breuer C, Breton A, Bronski J, Buderus S, Cananzi M, Coopman S, Crémilleux C, Dabadie A, Dumant-Forest C, Egritas Gurkan O, Fabre A, Fischer A, German Diaz M, Gonzalez-Lama Y, Goulet O, Guariso G, Gurcan N, Homan M, Hugot JP, Jeziorski E, Karanika E, Lachaux A, Lewindon P, Lima R, Magro F, Major J, Malamut G, Mas E, Mattyus I, Mearin LM, Melek J, Navas-Lopez VM, Paerregaard A, Pelatan C, Pigneur B, Pinto Pais I, Rebeuh J, Romano C, Siala N, Strisciuglio C, Tempia-Caliera M, Tounian P, Turner D, Urbonas V, Willot S, Ruemmele FM, Cerf-Bensussan N.

J Crohns Colitis. 2018 May 18. doi: 10.1093/ecco-jcc/jjy068. [Epub ahead of print]

15.

Human ALPI deficiency causes inflammatory bowel disease and highlights a key mechanism of gut homeostasis.

Parlato M, Charbit-Henrion F, Pan J, Romano C, Duclaux-Loras R, Le Du MH, Warner N, Francalanci P, Bruneau J, Bras M, Zarhrate M, Bègue B, Guegan N, Rakotobe S, Kapel N, De Angelis P, Griffiths AM, Fiedler K, Crowley E, Ruemmele F, Muise AM, Cerf-Bensussan N.

EMBO Mol Med. 2018 Apr;10(4). pii: e8483. doi: 10.15252/emmm.201708483.

16.

Human Gut Symbiont Roseburia hominis Promotes and Regulates Innate Immunity.

Patterson AM, Mulder IE, Travis AJ, Lan A, Cerf-Bensussan N, Gaboriau-Routhiau V, Garden K, Logan E, Delday MI, Coutts AGP, Monnais E, Ferraria VC, Inoue R, Grant G, Aminov RI.

Front Immunol. 2017 Sep 26;8:1166. doi: 10.3389/fimmu.2017.01166. eCollection 2017.

17.

Lactobacillus paracasei feeding improves immune control of influenza infection in mice.

Belkacem N, Serafini N, Wheeler R, Derrien M, Boucinha L, Couesnon A, Cerf-Bensussan N, Gomperts Boneca I, Di Santo JP, Taha MK, Bourdet-Sicard R.

PLoS One. 2017 Sep 20;12(9):e0184976. doi: 10.1371/journal.pone.0184976. eCollection 2017.

18.

A New Case of Congenital Malabsorptive Diarrhea and Diabetes Secondary to Mutant Neurogenin-3.

Germán-Díaz M, Rodriguez-Gil Y, Cruz-Rojo J, Charbit-Henrion F, Cerf-Bensussan N, Manzanares-López Manzanares J, Moreno-Villares JM.

Pediatrics. 2017 Aug;140(2). pii: e20162210. doi: 10.1542/peds.2016-2210.

19.

First Identification of Biallelic Inherited DUOX2 Inactivating Mutations as a Cause of Very Early Onset Inflammatory Bowel Disease.

Parlato M, Charbit-Henrion F, Hayes P, Tiberti A, Aloi M, Cucchiara S, Bègue B, Bras M, Pouliet A, Rakotobe S, Ruemmele F, Knaus UG, Cerf-Bensussan N.

Gastroenterology. 2017 Aug;153(2):609-611.e3. doi: 10.1053/j.gastro.2016.12.053. Epub 2017 Jul 3. No abstract available.

PMID:
28683258
20.

Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.

Vicari AP, Schoepfer AM, Meresse B, Goffin L, Léger O, Josserand S, Guégan N, Yousefi S, Straumann A, Cerf-Bensussan N, Simon HU, Chvatchko Y.

MAbs. 2017 Aug/Sep;9(6):927-944. doi: 10.1080/19420862.2017.1332553. Epub 2017 Jun 5.

21.

Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world.

Schnupf P, Gaboriau-Routhiau V, Sansonetti PJ, Cerf-Bensussan N.

Curr Opin Microbiol. 2017 Feb;35:100-109. doi: 10.1016/j.mib.2017.03.004. Epub 2017 Apr 25. Review.

PMID:
28453971
22.

[Gut microbiota and development of the immune system].

Gaboriau-Routhiau V, Cerf-Bensussan N.

Med Sci (Paris). 2016 Nov;32(11):961-967. doi: 10.1051/medsci/20163211011. Epub 2016 Dec 23. Review. French.

23.

Atypical Manifestation of LPS-Responsive Beige-Like Anchor Deficiency Syndrome as an Autoimmune Endocrine Disorder without Enteropathy and Immunodeficiency.

Bakhtiar S, Ruemmele F, Charbit-Henrion F, Lévy E, Rieux-Laucat F, Cerf-Bensussan N, Bader P, Paetow U.

Front Pediatr. 2016 Sep 14;4:98. doi: 10.3389/fped.2016.00098. eCollection 2016.

24.

IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria.

Flannigan KL, Ngo VL, Geem D, Harusato A, Hirota SA, Parkos CA, Lukacs NW, Nusrat A, Gaboriau-Routhiau V, Cerf-Bensussan N, Gewirtz AT, Denning TL.

Mucosal Immunol. 2017 May;10(3):673-684. doi: 10.1038/mi.2016.80. Epub 2016 Sep 14.

25.

Interleukin-15-Dependent T-Cell-like Innate Intraepithelial Lymphocytes Develop in the Intestine and Transform into Lymphomas in Celiac Disease.

Ettersperger J, Montcuquet N, Malamut G, Guegan N, Lopez-Lastra S, Gayraud S, Reimann C, Vidal E, Cagnard N, Villarese P, Andre-Schmutz I, Gomes Domingues R, Godinho-Silva C, Veiga-Fernandes H, Lhermitte L, Asnafi V, Macintyre E, Cellier C, Beldjord K, Di Santo JP, Cerf-Bensussan N, Meresse B.

Immunity. 2016 Sep 20;45(3):610-625. doi: 10.1016/j.immuni.2016.07.018. Epub 2016 Sep 6.

26.

Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome.

Charbit-Henrion F, Jeverica AK, Bègue B, Markelj G, Parlato M, Avčin SL, Callebaut I, Bras M, Parisot M, Jazbec J, Homan M, Ihan A, Rieux-Laucat F, Stolzenberg MC, Ruemmele FM, Avčin T, Cerf-Bensussan N; GENIUS Group.

J Pediatr Gastroenterol Nutr. 2017 Mar;64(3):378-384. doi: 10.1097/MPG.0000000000001262.

PMID:
27253662
27.

Respective Roles of Hematopoietic and Nonhematopoietic Nod2 on the Gut Microbiota and Mucosal Homeostasis.

Alnabhani Z, Hugot JP, Montcuquet N, Le Roux K, Dussaillant M, Roy M, Leclerc M, Cerf-Bensussan N, Lepage P, Barreau F.

Inflamm Bowel Dis. 2016 Apr;22(4):763-73. doi: 10.1097/MIB.0000000000000749.

PMID:
26963567
28.

Coeliac disease &gluten sensitivity: Epithelial stress enters the dance in coeliac disease.

Cerf-Bensussan N, Meresse B.

Nat Rev Gastroenterol Hepatol. 2015 Sep;12(9):491-2. doi: 10.1038/nrgastro.2015.120. Epub 2015 Jul 21. No abstract available.

PMID:
26194946
29.

Celiac disease in children.

Garnier-Lengliné H, Cerf-Bensussan N, Ruemmele FM.

Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):544-51. doi: 10.1016/j.clinre.2015.05.024. Epub 2015 Jul 15. Review.

PMID:
26186878
30.

MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells.

Ohnmacht C, Park JH, Cording S, Wing JB, Atarashi K, Obata Y, Gaboriau-Routhiau V, Marques R, Dulauroy S, Fedoseeva M, Busslinger M, Cerf-Bensussan N, Boneca IG, Voehringer D, Hase K, Honda K, Sakaguchi S, Eberl G.

Science. 2015 Aug 28;349(6251):989-93. doi: 10.1126/science.aac4263. Epub 2015 Jul 9.

31.

Diversification of memory B cells drives the continuous adaptation of secretory antibodies to gut microbiota.

Lindner C, Thomsen I, Wahl B, Ugur M, Sethi MK, Friedrichsen M, Smoczek A, Ott S, Baumann U, Suerbaum S, Schreiber S, Bleich A, Gaboriau-Routhiau V, Cerf-Bensussan N, Hazanov H, Mehr R, Boysen P, Rosenstiel P, Pabst O.

Nat Immunol. 2015 Aug;16(8):880-8. doi: 10.1038/ni.3213. Epub 2015 Jun 29.

PMID:
26147688
32.

Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.

Scialom S, Malamut G, Meresse B, Guegan N, Brousse N, Verkarre V, Derrieux C, Macintyre E, Seksik P, Savoye G, Cadiot G, Vuitton L, Marthey L, Carbonnel F, Cerf-Bensussan N, Cellier C.

PLoS One. 2015 Jun 23;10(6):e0125024. doi: 10.1371/journal.pone.0125024. eCollection 2015.

33.

The role of animal models in unravelling therapeutic targets in coeliac disease.

Costes LM, Meresse B, Cerf-Bensussan N, Samsom JN.

Best Pract Res Clin Gastroenterol. 2015 Jun;29(3):437-50. doi: 10.1016/j.bpg.2015.04.007. Epub 2015 May 8. Review.

PMID:
26060108
34.

Identification of new cases of severe enteropathy has recently increased the spectrum of intestinal non-celiac villous atrophy.

Malamut G, Cerf-Bensussan N, Cellier C.

Expert Rev Gastroenterol Hepatol. 2015 Jun;9(6):719-21. doi: 10.1586/17474124.2015.1039990.

PMID:
25990839
35.

Enteropathy-associated T-cell lymphoma: improving treatment strategies.

Nijeboer P, Malamut G, Mulder CJ, Cerf-Bensussan N, Sibon D, Bouma G, Cellier C, Hermine O, Visser O.

Dig Dis. 2015;33(2):231-5. doi: 10.1159/000369542. Epub 2015 Apr 22. Review.

PMID:
25925928
36.

Therapy in RCDII: Rationale for Combination Strategies?

Nijeboer P, Malamut G, Bouma G, Cerf-Bensussan N, Koning F, van Bergen J, Cellier C, Mulder CJ.

Dig Dis. 2015;33(2):227-30. doi: 10.1159/000381076. Epub 2015 Apr 22. Review.

PMID:
25925927
37.

Interleukin-15, a master piece in the immunological jigsaw of celiac disease.

Meresse B, Korneychuk N, Malamut G, Cerf-Bensussan N.

Dig Dis. 2015;33(2):122-30. doi: 10.1159/000369521. Epub 2015 Apr 22. Review.

PMID:
25925912
38.

Growth and host interaction of mouse segmented filamentous bacteria in vitro.

Schnupf P, Gaboriau-Routhiau V, Gros M, Friedman R, Moya-Nilges M, Nigro G, Cerf-Bensussan N, Sansonetti PJ.

Nature. 2015 Apr 2;520(7545):99-103. doi: 10.1038/nature14027. Epub 2015 Jan 19.

39.

Commensal microbiota influence systemic autoimmune responses.

Van Praet JT, Donovan E, Vanassche I, Drennan MB, Windels F, Dendooven A, Allais L, Cuvelier CA, van de Loo F, Norris PS, Kruglov AA, Nedospasov SA, Rabot S, Tito R, Raes J, Gaboriau-Routhiau V, Cerf-Bensussan N, Van de Wiele T, Eberl G, Ware CF, Elewaut D.

EMBO J. 2015 Feb 12;34(4):466-74. doi: 10.15252/embj.201489966. Epub 2015 Jan 19.

40.

Lessons from rodent models in celiac disease.

Korneychuk N, Meresse B, Cerf-Bensussan N.

Mucosal Immunol. 2015 Jan;8(1):18-28. doi: 10.1038/mi.2014.102. Epub 2014 Oct 29. Review.

PMID:
25354320
41.

Olmesartan-associated enteropathy: results of a national survey.

Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F, Mesnard B, Chayvialle JA, Savoye G, Druez A, Parlier D, Abitbol V, Gompel M, Eoche M, Poncin E, Bobichon R, Colardelle P, Wils P, Salloum H, Peschard S, Zerbib F, Méresse B, Cerf-Bensussan N, Malamut G, Carbonnel F.

Aliment Pharmacol Ther. 2014 Nov;40(9):1103-9. doi: 10.1111/apt.12937. Epub 2014 Sep 9.

42.

Genome Sequence of "Candidatus Arthromitus" sp. Strain SFB-Mouse-NL, a Commensal Bacterium with a Key Role in Postnatal Maturation of Gut Immune Functions.

Bolotin A, de Wouters T, Schnupf P, Bouchier C, Loux V, Rhimi M, Jamet A, Dervyn R, Boudebbouze S, Blottière HM, Sorokin A, Snel J, Cerf-Bensussan N, Gaboriau-Routhiau V, van de Guchte M, Maguin E.

Genome Announc. 2014 Jul 17;2(4). pii: e00705-14. doi: 10.1128/genomeA.00705-14.

43.

Reply: To PMID 24316103.

Malamut G, Cerf-Bensussan N, Cellier C.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):620. doi: 10.1016/j.cgh.2014.07.015. Epub 2014 Jul 12. No abstract available.

PMID:
25019699
44.

Segmented filamentous bacterium uses secondary and tertiary lymphoid tissues to induce gut IgA and specific T helper 17 cell responses.

Lécuyer E, Rakotobe S, Lengliné-Garnier H, Lebreton C, Picard M, Juste C, Fritzen R, Eberl G, McCoy KD, Macpherson AJ, Reynaud CA, Cerf-Bensussan N, Gaboriau-Routhiau V.

Immunity. 2014 Apr 17;40(4):608-20. doi: 10.1016/j.immuni.2014.03.009.

45.

Interleukin 15 and CD4⁺ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen.

Korneychuk N, Ramiro-Puig E, Ettersperger J, Schulthess J, Montcuquet N, Kiyono H, Meresse B, Cerf-Bensussan N.

Gastroenterology. 2014 Apr;146(4):1017-27. doi: 10.1053/j.gastro.2013.12.023. Epub 2013 Dec 18.

PMID:
24361466
46.

Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features.

Malamut G, Meresse B, Kaltenbach S, Derrieux C, Verkarre V, Macintyre E, Ruskone-Fourmestraux A, Fabiani B, Radford-Weiss I, Brousse N, Hermine O, Cerf-Bensussan N, Cellier C.

Clin Gastroenterol Hepatol. 2014 Apr;12(4):599-608.e1. doi: 10.1016/j.cgh.2013.11.028. Epub 2013 Dec 4.

PMID:
24316103
47.

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.

Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Bérard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Doré J, Kroemer G, Lepage P, Boneca IG, Ghiringhelli F, Zitvogel L.

Science. 2013 Nov 22;342(6161):971-6. doi: 10.1126/science.1240537.

48.

Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group.

Pigneur B, Escher J, Elawad M, Lima R, Buderus S, Kierkus J, Guariso G, Canioni D, Lambot K, Talbotec C, Shah N, Begue B, Rieux-Laucat F, Goulet O, Cerf-Bensussan N, Neven B, Ruemmele FM.

Inflamm Bowel Dis. 2013 Dec;19(13):2820-8. doi: 10.1097/01.MIB.0000435439.22484.d3.

PMID:
24216686
49.

Host interactions with Segmented Filamentous Bacteria: an unusual trade-off that drives the post-natal maturation of the gut immune system.

Schnupf P, Gaboriau-Routhiau V, Cerf-Bensussan N.

Semin Immunol. 2013 Nov 30;25(5):342-51. doi: 10.1016/j.smim.2013.09.001. Epub 2013 Oct 31. Review.

PMID:
24184014
50.

Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form.

Salomon J, Goulet O, Canioni D, Brousse N, Lemale J, Tounian P, Coulomb A, Marinier E, Hugot JP, Ruemmele F, Dufier JL, Roche O, Bodemer C, Colomb V, Talbotec C, Lacaille F, Campeotto F, Cerf-Bensussan N, Janecke AR, Mueller T, Koletzko S, Bonnefont JP, Lyonnet S, Munnich A, Poirier F, Smahi A.

Hum Genet. 2014 Mar;133(3):299-310. doi: 10.1007/s00439-013-1380-6. Epub 2013 Oct 19.

PMID:
24142340

Supplemental Content

Loading ...
Support Center